⚠ Evidence note: An aging clock is a statistical model, not a measurement of aging itself; predictive validity varies widely between clocks and populations.
Proteomic and Metabolomic Aging Signatures
Current understanding
Organ-specific and plasma-proteome clocks — the current research frontier in aging measurement.
Evidence log
- 2026-11-12 — Aging Remodels the Female Skeletal Muscle Proteome Toward Matrix, Chromatin and Lysosomal Programs that Track Loss of Physical Function: [human-observational] Observational vastus lateralis biopsy proteomics in younger and older women identified a 24-protein aging signature enriched in extracellular-matrix, chromatin, and lysosomal/SASP factors, highlighting HMGB1/2 and correlating with lower grip strength and slower gait, without establishing prospective functional-decline prediction, independent validation, test-retest reliability, or that shifting the signature improves function or demonstrates de-aging. [human-observational] (novelty: 3)
- 2026-11-13 — The plasma proteins GSN, F2, CRTAC1, and HP are associated with multigenerational health, longevity, and resilience.: [human-observational] Human observational study spanning two generations with up to 22 years of follow-up associated plasma GSN, F2, CRTAC1, and HP levels with familial longevity, favorable cardiometabolic healthspan, and mid- to late-life survival, adding outcome-linked protein candidates without establishing causality, test-retest reliability, or that changing their levels improves outcomes or demonstrates de-aging. [human-observational] (novelty: 3)
- 2026-11-01 — Immunophenotypic Profiles of General Chinese Population during Natural Aging.: [human-observational] Observational immune profiling in 605 healthy Chinese individuals adds a 50-subset CyTOF immune-age signature associated with lifestyle and physiological markers as a complementary cellular measurement modality, not validation of plasma proteomic or metabolomic clocks or evidence that changing an age signature improves health outcomes. [human-observational] (novelty: 3)
- 2026-11-11 — Longevitomics as the Science of the Longevitome: Towards a Unified Systems Science of Healthy Longevity.: [expert-opinion] Longevitomics framework review positions proteomic and metabolomic signatures as inputs to integrated longevity models rather than standalone readouts, adding conceptual synthesis rather than independent biomarker validation or evidence that shifting a signature demonstrates de-aging. [expert-opinion] (novelty: 3)
- 2026-10-21 — Relationship Between Social Isolation, Loneliness, and Systemic Inflammation: A Scoping Review of Biological Signatures and Clinical Outcomes.: cross-connection with epigenetic-clocks: [human-observational] The review links social isolation and loneliness to both proteomic alterations and epigenetic age acceleration, connecting two biomarker modalities without demonstrating that they measure the same process or independently mediate clinical risk. (novelty: 3)
- 2026-07-30 — Circulating Amino Acids Independently Predict Longitudinal Progression of Cardio-Ankle Vascular Index in Japanese Older Adults: The Kyotango Longevity Cohort Study.: [human-observational] Three-year prospective Kyotango Longevity Cohort study in older Japanese adults found higher baseline circulating leucine, isoleucine, and glutamic acid independently associated with faster arterial-stiffness progression measured by cardio-ankle vascular index (CAVI), extending longitudinal metabolomic-marker evidence without establishing cardiovascular-event prediction, causality, or benefit from lowering these metabolites. [human-observational] (novelty: 3)
- 2026-10-07 — Lysine degradation-related metabolic remodeling in sarcopenia: Mendelian randomization prioritization and multi-omics-based characterization.: [human-observational] Metabolome-wide Mendelian randomization integrated with human muscle and serum multi-omics prioritized lysine degradation and impaired trimethyllysine-derived carnitine biosynthesis as candidate contributors to reduced appendicular lean mass, with causal interpretation dependent on genetic-instrument assumptions and prospective prediction, test-retest reliability, and intervention responsiveness not established by the supplied finding. [human-observational] (novelty: 3)
- 2026-10-15 — Proteomic and β-hydroxybutyrylation Landscapes Reveal AMPKα2-Associated Modulation in HUCMSC-Derived Exosome-Mediated Amelioration of Cardiac Aging.: [animal-model] Mouse intervention study pairing proteomics with lysine β-hydroxybutyrylation profiling reported improved age-associated cardiac dysfunction after human umbilical cord MSC-derived exosome treatment and implicated an AMPKα2/sirtuin-associated pathway, identifying intervention-responsive tissue signatures rather than a validated aging clock, with human outcome prediction and test-retest reliability not established by the supplied finding. [animal-model] (novelty: 3)
- 2026-06-01 — Handgrip strength and risk of common infections and sepsis: Two prospective cohorts with proteomic mediation analysis.: [human-observational] Two prospective human cohorts linked lower handgrip strength to higher subsequent infection and sepsis risk, with proteomic mediation analysis identifying GDF15 and PLAUR as partial statistical mediators rather than established causal pathways or validated intervention targets. [human-observational] (novelty: 3)
- 2026-10-15 — Urinary organic acid analysis in preventive health assessment and healthy-aging research: A state-of-the-art review of evidence and methodological limitations.: [expert-opinion] State-of-the-art review, no new primary data, summarizes associations of urinary organic acid and metabolomic profiles with adiposity, metabolic health, and aging phenotypes but finds no demonstrated healthy-aging benefit from test-guided interventions; profile changes therefore cannot be interpreted as proof of de-aging. [expert-opinion] (novelty: 3)
- 2026-10-29 — Metabolic exhaustion underlies sarcopenic obesity susceptibility in aging mice as revealed by multi-omics factor analysis.: [animal-model] Multi-omics factor analysis in aging mice implicated skeletal-muscle metabolic exhaustion and incomplete beta-oxidation rather than obesity severity in sarcopenic-obesity susceptibility, identifying circulating acetylcarnitine and pantothenol as a high-discrimination two-metabolite signature; independent replication, human outcome prediction, test-retest reliability, and intervention responsiveness are not established by the supplied finding. [animal-model] (novelty: 3)
- 2026-10-09 — Brain care score and retinal health: structural and metabolic insights from the UK Biobank.: cross-connection with retinal-oct-biological-age: Metabolomic signatures (lipids, unsaturated fatty acids, BCAAs) are implicated as mediators between a composite brain-care lifestyle score and OCT-derived retinal age gap — links the retinal structural-aging layer to plasma metabolomic aging readouts within one UK Biobank analysis. (novelty: 3)
- 2026-10-07 — Plasma proteomic signatures of biological aging and metabolic dysfunction-associated steatotic liver disease risk: a prospective cohort study.: UK Biobank prospective proteomic mediation study tied four biological-age metrics to incident MASLD via a shared five-protein core (AXL, CCL19, CPM, REN, TNFRSF11B) implicating multi-organ immune-inflammatory pathways — extends the proteomic-signature catalog into a MASLD mediation use case, observational and mediation-based rather than causal. [human-observational] (novelty: 3)
- 2026-09-28 — Uncertainty redefines biological age: UK Biobank study (>450k) ties BAU to reduced coherence of aging signals across molecular and organ-level proteomic/metabolomic readouts, arguing that disagreement between omic signatures carries prognostic weight separate from any single composite age score — adds a cross-omic dispersion metric to the signature catalog, observational. [human-observational] (novelty: 4)
- 2026-09-29 — Westlake Longevity Cohort: 2026 — Westlake Longevity Cohort (We-Longevity) protocol will layer multi-omic (including proteomic/metabolomic) profiling on Chinese centenarians and nonagenarians with longitudinal trajectories — a planned addition to East-Asian reference distributions for aging signatures, no data yet. [expert-opinion] (novelty: 3)
- 2026-10-02 — Multimodal Ageing Biomarkers and Plasma Proteomic Signatures Associated With All‐Cause Mortality: LBC1936 plasma-proteomic screen (2,923 proteins) identified a 368-protein signature associated with 16-year all-cause mortality led by GDF15, WFDC2, and TIMP1; organ-specific proteomic age clocks (liver, immune, heart) predicted mortality but underperformed vs GrimAge2 and multimodal physiologic measures — reinforces the recurrent GDF15/WFDC2 proteomic-mortality trio. [human-observational] (novelty: 3)
- 2026-10-01 — Organ-Specific Proteomic Aging Clocks Reveal Complexities Underlying the Healthy Drinking Paradox.: 2026-09-24 — Perspective on organ-specific proteomic clocks and alcohol argues contradictory organ-level associations with drinking likely reflect confounding and clock-construction differences rather than true protection, warning that face-value readings understate alcohol’s known harms — a methodological critique layered on the proteomic-signature catalog, no new primary data. [expert-opinion] (novelty: 3)
- 2026-10-06 — Association of systemic aging and frailty with retinal alterations: insights from an integrated exposome and metabolome framework.: cross-connection with retinal-macular-thickness-aging: Plasma metabolomic signatures mediated a substantial share of the aging-clock / frailty → macular-thickness associations, linking metabolomic aging panels to a retinal structural phenotype. (novelty: 3)
- 2026-10-06 — Intrinsic capacity modifies the risk of depression and anxiety through metabolomic signature.: UK Biobank analysis derived a 59-metabolite signature that partially mediates the association between WHO intrinsic-capacity deficits and incident depression/anxiety — adds a mental-health-outcome-linked metabolomic mediator to the signature catalog, mediation only and not causal. [human-observational] (novelty: 3)
- 2025-12-15 — Discrimination of normal from slow-aging mice by plasma metabolomic and proteomic features.: Mouse plasma metabolomic+proteomic XGBoost classifier discriminated slow-aging from control animals and generalized to held-out anti-aging interventions, both sexes, and long-lived mutants, with longer-chain triglycerides enriched in slow-aging mice — adds a cross-intervention, cross-sex preclinical plasma signature with a concrete lipid-chain-length pattern to the metabolomic/proteomic catalog, no human validation. [animal-model] (novelty: 3)
- 2026-07-06 — From organ age gaps to precision geromedicine: Multi-omic and imaging frameworks for heterogeneous biological aging.: Review extends the organ-specific proteomic/metabolomic-clock catalog with an ORGAN-AGE interpretive overlay, cautioning that plasma-derived organ age scores typically cannot localize their tissue source and should not be read as direct organ-to-organ propagation. [expert-opinion] (novelty: 3)
- 2026-08-18 — Multivariable-adjusted multi-omics signatures reveal gut microbial functional alterations and metabolic dysregulation in intrinsic capacity decline.: Serum metabolomics component (n=56 metabolites) of a multi-omics IC-decline study highlights amino-acid and carnitine pathway alterations plus bile-acid and senescence-related metabolites embedded in a microbiome–metabolome network after multivariable adjustment — extends the metabolomic-signature catalog to the WHO intrinsic capacity phenotype, association only. [human-observational] (novelty: 3)
- 2026-07-15 — Chronic kidney disease-stratified plasma proteomic signatures of probable sarcopenia: A UK biobank cohort study.: UK Biobank plasma proteomic study (n≈52k, 2920 Olink proteins) stratified by CKD status derived a probable-sarcopenia signature led by COL6A3 and GDF15 spanning ECM remodelling, inflammation, renal dysfunction, and lipid-metabolic stress, with prospective and cis-pQTL support — extends the proteomic-signature catalog into a CKD-conditioned sarcopenia use case and reinforces GDF15 as a recurrent anchor, association + MR-flavored but not interventional. [human-observational] (novelty: 3)
- 2026-10-01 — Multimodal Ageing Biomarkers and Plasma Proteomic Signatures Associated With All-Cause Mortality.: LBC1936 plasma-proteomic screen of 2,923 proteins identified a 368-protein signature associated with 16-year all-cause mortality led by GDF15, WFDC2, and TIMP1, while organ-specific proteomic age clocks (liver, immune, heart) predicted mortality but underperformed vs GrimAge2 and multimodal physiologic measures — reinforces the recurrent GDF15/WFDC2 proteomic-mortality trio and shows single-protein signatures can match or exceed derived organ-age composites. [human-observational] (novelty: 3)
- 2025-11-18 — Glycemic status-dependent proteomic signatures of biological aging for health risk prediction.: UK Biobank Olink plasma proteomic study stratified by glycemic status (normoglycemia, prediabetes, diabetes) built glycemic-specific Proteomic Aging Scores (ProAS) that predict all-cause mortality and incident disease beyond conventional risk factors, with GDF15, EDA2R, and WFDC2 recurring as shared top markers across strata — extends proteomic-signature construction into glycemic-context-conditioned clocks, observational and association-only. [human-observational] (novelty: 3)
- 2026-10-01 — A Deep-Learning Based Biomarker of Systemic Cellular Senescence Burden to Predict Mortality and Health Outcomes.: Deep-learning-derived blood proteomics SASP Score independently predicts mortality and multiple incident chronic diseases in large observational data and shifted significantly over 18 months of multimodal exercise in an external RCT cohort — adds a composite proteomic senescence-burden signature to the catalog with a rare paired intervention-responsiveness readout, though score movement is not yet shown to translate into outcome improvement. [human-observational] (novelty: 4)
- 2026-10-01 — Traditional Chinese Medicine Formulas in Delaying Aging: From Theoretical Foundations to Molecular Mechanisms and Translational Perspectives.: Narrative review of TCM multi-herb formulas proposes proteomic aging clocks (alongside network pharmacology and AI target screening) as a readout layer for multi-component geroprotective candidates — positions proteomic signatures as a translational endpoint for TCM research, no primary signature data. [expert-opinion] (novelty: 3)
- 2026-09-24 — Organ‐Specific Proteomic Aging Clocks Reveal Complexities Underlying the Healthy Drinking Paradox: Observational study applying organ-specific proteomic aging clocks to alcohol intake finds organ-dependent associations that complicate the healthy-drinking paradox — extends the proteomic-clock catalog into an alcohol-exposure use case, association only and no evidence that shifting any organ score reflects true de-aging. [human-observational] (novelty: 3)
- 2026-07-08 — Long-term exposure to air pollution, proteomic aging clocks, and liver-related outcomes in Chinese adults.: China Kadoorie Biobank cohort study links long-term ambient air pollutant exposure (single pollutants and mixtures) to incident liver events and mortality in Chinese adults, with a plasma proteomic aging clock (ProtAge) acting as a partial mediator — extends proteomic-signature evidence into an environmental-exposure→organ-outcome mediation role, observational and mediation-based rather than causal. [human-observational] (novelty: 3)
- 2026-09-25 — Longitudinal proteomic organ-specific aging in heart failure.: Longitudinal HF cohort applying proteomic organ-age gaps found multi-organ aging accelerates before adverse events and that kidney, lung, and immune organ age gaps predict outcomes independently of NT-proBNP and troponin T — first longitudinal (not cross-sectional) use of organ-specific proteomic clocks in heart failure, observational. [human-observational] (novelty: 4)
- 2026-09-15 — Common and distinct plasma proteomic signature of aerobic and motor physical activity interventions and their link to episodic memory.: Secondary plasma proteomics analysis of a 12-week randomized activity trial (n=34 healthy older adults) identified a shared 24-protein inflammatory signature across aerobic and gross-motor exercise plus a distinct 33-protein aerobic-specific immune/vascular signature associated with episodic memory improvement — extends the exercise-responsive proteomic-signature catalog with modality-differential mechanistic candidates, exploratory and underpowered. [human-rct] (novelty: 3)
- 2026-09-16 — Sex-specific biological aging clocks across organs and omics.: Sex-stratified construction of 38 organ-system aging clocks surfaced organ-resolved proteomic networks that diverge between females and males and predict disease/mortality differently than sex-pooled models — extends proteomic-signature methodology into a sex-resolved layer, observational and derivative rather than a new outcome trial. [human-observational] (novelty: 4)
- 2026-09-01 — An open benchmark and language models for AI in aging biology.: LongevityBench (open aging-biology AI benchmark) identifies omics age prediction as the hardest of its tested domains for frontier LLMs, while releasing compact fine-tuned Longevity-LLMs plus an agentic research interface — an evaluation-layer resource for proteomic/metabolomic signature work, not a new signature or intervention-responsiveness result. [expert-opinion] (novelty: 4)
- 2026-09-16 — Quantitative proteomics reveals coordinated changes in the proteome during replicative senescence.: In vitro replicative-senescence time-course proteomics (mass-spec) mapped a coordinated proteostasis-shaped signature — chromatin and translation-machinery loss, mitochondrial protein insolubility, and impaired autophagy/proteasome activity — providing a cellular-model proteomic reference for senescent-cell signatures rather than an in vivo aging clock. [mechanism-plausible] (novelty: 3)
- 2026-09-20 — CSenescence-associated-secretory phenotype proteins and inflammatory pathways are involved in psychosis: A transdiagnostic study using the Human Connectome Project for early psychosis (HCP-EP) data.: HCP-EP cross-sectional plasma proteomics found early-psychosis patients had an elevated SASP protein index and enrichment of TNF response and monocyte chemotaxis pathways relative to controls, correlating with higher BMI and lower psychological well-being — extends the SASP proteomic-signature catalog into a psychiatric premature-aging phenotype, association only. [human-observational] (novelty: 3)
- 2026-09-26 — Plasma and cerebrospinal fluid proteomics reveal distinct patterns of senescence and neuropathology in aging rhesus macaques.: Cross-sectional rhesus macaque plasma and CSF proteomics across the lifespan identified compartment-specific senescence and neuropathology signatures (including human-benchmarked neurosenescence and inflammaging markers) with geriatric CSF subclusters — extends the proteomic-signature catalog into paired blood/CSF NHP reference data for translational biomarker work, no outcome or intervention data. [animal-model] (novelty: 3)
- 2026-06-06 — Association between bile acid metabolism and sarcopenia in older adults.: Matched case-control serum metabolomics in older adults linked elevated 3β-HDCA and GLCA to primary sarcopenia (3β-HDCA also tracking slower 6-m gait speed), with TLCA-linked sarcopenia risk markedly amplified in long sleepers (>8 h) — adds specific bile-acid metabolites to the metabolomic-signature catalog on a gut–bile-acid–muscle axis, cross-sectional and not causal. [human-observational] (novelty: 3)
- 2026-09-07 — Integration of proteomic aging clocks in a phase 2a clinical trial supports simultaneous geroprotective assessment: News coverage (Nature.com) of a phase 2a clinical trial embedding proteomic aging clocks as a simultaneous geroprotective readout — a measurement-layer application inside an interventional trial, no primary efficacy data disclosed in the report. [expert-opinion] (novelty: 3)
- 2026-09-09 — The redox architecture of gestational diabetes mellitus: from cellular stress engine to epigenetic and mitochondrial rewiring.: Review positions GDM-related oxidative stress as producing distinctive maternal and offspring proteomic/metabolic redox signatures (mitochondrial, inflammatory, metabolic-memory markers) worth cataloging alongside plasma-proteome aging clocks — commentary, no new signature or outcome data. [expert-opinion] (novelty: 3)
- 2026-09-12 — Proteomic signatures of systemic inflammation in aging, multimorbidity, and mortality.: UK Biobank proteomic study derived a compact Proteomic Inflammaging Score (PIS) anchored on six inflammatory biomarkers that outperformed conventional inflammatory and aging markers for all-cause mortality and multimorbidity prediction at population scale — observational, no intervention responsiveness data. [human-observational] (novelty: 3)
- 2026-08-18 — A Novel Approach Utilizing Organ Specific Age Proteomics: Proposed application of organ-specific plasma proteomic age signatures paired with p16INK4A T-cell immune-aging readouts pre/post adjuvant chemotherapy in early-stage breast cancer, framed as a risk-stratification use case for cardiac/neurologic/functional late toxicities — concept/proposal repurposing existing organ-clock methodology, no new signature or outcome data. [expert-opinion] (novelty: 3)
- 2026-07-08 — Deciphering the Factors of Longevity Through a Multi-Omics Study in Long-Lived Individuals in Hong Kong: Proposed Hong Kong long-lived-individual cohort would layer proteomic and metabolomic profiling on a Chinese centenarian population — protocol only, no signatures reported yet, so it flags a gap in East Asian omic reference data rather than adding evidence. [expert-opinion] (novelty: 3)
- 2026-08-27 — Associations Between Accelerometer‐Assessed Sleep Patterns, Proteomic Signatures, and Hallmarks of Aging in Adulthood: Aging Cell observational study links accelerometer-measured adulthood sleep patterns to plasma proteomic signatures and hallmarks of aging — multi-layer sleep–omics association, no intervention data and effect sizes not fully specified in abstract. [human-observational] (novelty: 3)
- 2026-05-08 — Ergothioneine as a potential geroprotector: Targeting molecular hallmarks of ageing and age-related diseases.: cross-connection with ergothioneine-aging-biomarker: Ergothioneine recurs as a declining metabolite in metabolomic aging signatures, linking the single-compound biomarker case to broader metabolomic clocks. (novelty: 3)
- 2026-06-19 — Amino acid and appendicular skeletal muscle mass insufficiency are associated to cognitive decline in Chinese population.: Multi-center Chinese metabolomics cohort (~1500) plus independent community cohort (~6000) found essential amino acid insufficiency combined with low appendicular skeletal muscle mass cross-sectionally associated with poorer cognition, proposing a peripheral metabolic-muscle signature linking body composition to brain aging — association only, cross-sectional, no intervention. [human-observational] (novelty: 3)
- 2026-06-22 — Age-related metabolomic signatures and stroke susceptibility in a population-based cohort.: Nested case-control NMR metabolomics in a large Chinese cohort identified subtype-specific circulating signatures (triglyceride-enriched lipoproteins, select low-MW metabolites) for ischemic stroke vs intracerebral hemorrhage, and a derived metabolic risk score partially mediated the age–stroke association beyond traditional cardiometabolic risk factors — observational mediation, not causal. [human-observational] (novelty: 3)
- 2026-07-24 — Decoding aging clocks from a metabolomic perspective.: Methodological review argues metabolomic clocks can capture dynamic metabolic fluctuations and tissue-specific aging better than epigenetic clocks, and proposes a structured workflow with a three-phase causal-validation strategy to improve predictive accuracy — framing/expert synthesis, no new primary data. [expert-opinion] (novelty: 3)
- 2026-07-31 — Urinary organophosphate metabolites, DNA methylation aging, and heart disease mortality in middle-aged and older adults: an exploratory cohort study withevidence of biological plausibility.: Same NHANES analysis flags urinary MonoPP (organophosphate metabolite) as a suggestive ~8–9% mediator of DETP–heart-disease mortality association alongside ZhangAge, extending metabolite-level aging signatures into environmental-exposure mediation but not passing FDR correction. [human-observational] (novelty: 3)
- 2026-07-06 — Microbiome and aging: Trajectories of microbiome age across human ecosystems and their systemic effects.: Review positions multi-habitat microbiome age as a complementary omics-layer biosignature to plasma proteomic/metabolomic aging signatures, arguing for integration across host and microbial ecosystems rather than substitution — synthesis-level claim, no new omics dataset. [expert-opinion] (novelty: 3)
- 2026-08-28 — Identifying novel druggable targets and repurposable drugs for premature ovarian insufficiency by integrated multiomics and causal inference analysis.: Proteome-wide MR + colocalization applied to POI extends the omics-signature toolkit from descriptive age-correlation to causal target nomination, surfacing EPHA4/FSTL3/NUCB2 as reproductive-aging protein candidates with in vitro but not clinical validation. [human-observational] (novelty: 3)
- 2026-07-03 — Delayed molecular aging, preservation of energy metabolism and enhanced exercise response in exercise-trained human muscle.: Human skeletal-muscle multiomic study (transcriptome/lipidome/metabolome) in older adults finds sustained training preserves ~50% of youth-like energy-metabolism molecular profiles and that higher fitness amplifies acute exercise responses in mitochondrial, lipid, stress, and NAD pathways — cross-sectional/associative muscle-tissue omics signature of trained aging, not evidence that training reverses a validated clock. [human-observational] (novelty: 3)
- 2026-06-29 — Mammalian aging involves genome-wide splicing degeneration leading to functional decline.: cross-connection with splicing-degeneration: Splicing degeneration extends multi-omic aging signatures into the post-transcriptional layer, complementing proteomic/metabolomic markers with an RNA-processing readout. (novelty: 3)
- 2026-07-01 — High Intrinsic Aerobic Capacity Is Associated With a Distinct Epigenetic and Signaling Profile in the Aged Rat Brain.: Same rat study: cortical proteomic/signaling profiling links intrinsic aerobic capacity to differential MAPK, AKT-mTOR-S6, synaptic, and inflammation-related pathways in the aged brain — a preclinical tissue-signaling signature of trait-level fitness, no outcome or clock construction. [animal-model] (novelty: 3)
- 2026-07-01 — Liver- and Immune-Enriched Molecular Signatures Associated With Mortality in Older Adults.: Community-dwelling older-adult cohort study built a 20-protein plasma mortality score enriched for liver- and immune-related proteins that outperformed metabolite scores and conventional clinical risk factors for all-cause mortality prediction, with directionally consistent external validation — incremental support that multi-omics plasma signatures beat standard risk panels in this age group, still association-only with no intervention data. [human-observational] (novelty: 3)
- 2026-07-28 — Circulating extracellular vesicles in plasma carry accessible molecular signatures of aging in mice.: Mouse cross-sectional plasma EV-enriched proteomics identified 272 age-correlated proteins (including senescence and neurodegenerative-disease-linked hits) with sex-specific divergence, and trained a proteomic clock predicting chronological age — preclinical proof-of-concept that circulating EV cargo is a tractable substrate for proteomic aging clocks, no outcome or intervention data. [animal-model] (novelty: 3)
- 2026-08-01 — Epigenetic aging in Alzheimer’s disease: Relation to proteome.: Same AD study links CSF proteomic network modules and hub proteins (connectivity, proteostasis, immune) to blood epigenetic age acceleration and amyloid/tau/neurodegeneration markers — a cross-tissue proteome–epigenome mapping in a disease cohort, association only. [human-observational] (novelty: 3)
- 2026-08-01 — An ANGPTL8-AKT2-mTOR Axis Drives Adipose Senescence and Aging-Related Functional Decline.: ANGPTL8 identified as a single-protein candidate aging biomarker: mouse KO extends lifespan (animal-model) and circulating levels correlate with biological age and mortality in human cohorts (human-observational); adds one more entrant to the proteomic-marker shortlist, not yet independently replicated. [human-observational] (novelty: 4)
- 2026-08-07 — Genetic drivers of protein changes over time: Findings, considerations, and approaches in TOPMed cohorts and UK Biobank.: Multi-cohort GWAS of longitudinal Olink proteomic slopes (MESA discovery; UKB and CARDIA replication) finds most unadjusted slope pQTLs fail to replicate and warns that baseline-adjusted slope pQTLs likely reflect collider bias, regression to the mean, or model misspecification rather than true genetic drivers of proteome aging — a cautionary methodological result for change-over-time proteomic phenotypes. [human-observational] (novelty: 3)
- 2026-08-02 — Rhythmic Metabolism in Osteosarcopenia: Emerging Evidence, a Chronometabolomic Framework for the Bone-Muscle Unit, and Research Priorities.: 2026 narrative review proposes ‘chronometabolomics’ — time-anchored metabolomic profiling of the bone–muscle unit in osteosarcopenia — as a research framework, while explicitly noting direct human evidence is scarce and listing light, sleep, protein timing, TRE, and exercise/medication timing as trial candidates rather than validated biomarkers. [expert-opinion] (novelty: 3)
- 2026-08-01 — Construction and Validation of Plasma Protein-Based Musculoskeletal Biological Age and Genetic and Environmental Risk Profiles.: UK Biobank plasma proteomic study (n=21,070) built two musculoskeletal-organ clocks (MSKAge, MSKAgeMort) from 39 proteins that predict mortality and musculoskeletal disease risk and surface genetic/environmental correlates of accelerated MSK aging — an organ-specific proteomic clock addition, not proof that moving the score reverses MSK aging. [human-observational] (novelty: 3)
- 2026-07-28 — The OmniAge compendium of aging omic biomarkers links mitotic clocks to clonal hematopoiesis and causality.: OmniAge assembles 413 aging omic biomarkers across 12 categories (epigenetic, transcriptomic, proteomic, mitotic, causal, etc.) into a single evaluation resource — a tooling/resource contribution enabling systematic cross-omic clock comparison rather than a new outcome finding. [human-observational] (novelty: 3)
- 2026-07-31 — Early life sugar rationing and ageing related diseases, biological ageing and mortality.: Same UK Biobank rationing cohort shows proteomic shifts aligned with AMPK activation and mTOR suppression in early-life-exposed adults, offering a rare human observational link between a defined early-life dietary exposure and later-life omics aging signatures. [human-observational] (novelty: 4)
Open questions
Related
Contributing findings
The plasma proteins GSN, F2, CRTAC1, and HP are associated with multigenerational health, longevity, and resilience.
13-nov-2026
novelty 3
per-area 3
strengthens
Aging Remodels the Female Skeletal Muscle Proteome Toward Matrix, Chromatin and Lysosomal Programs that Track Loss of Physical Function
12-nov-2026
novelty 3
per-area 3
strengthens
Multiomics Reveals a Production Signature Resembling Mammalian Metabolic Ageing and That Dietary Spermidine Enhances Lipid Handling in Farmed Salmon
12-nov-2026
novelty 2
per-area 2
strengthens
Longevitomics as the Science of the Longevitome: Towards a Unified Systems Science of Healthy Longevity.
11-nov-2026
novelty 3
per-area 3
strengthens
Systems Investigation of Vaccine Responses in Aging and Frailty
10-nov-2026
novelty 2
per-area 2
mentions
Immunophenotypic Profiles of General Chinese Population during Natural Aging.
01-nov-2026
novelty 3
per-area 3
strengthens
Metabolic exhaustion underlies sarcopenic obesity susceptibility in aging mice as revealed by multi-omics factor analysis.
29-oct-2026
novelty 3
per-area 3
strengthens
Proteomic and β-hydroxybutyrylation Landscapes Reveal AMPKα2-Associated Modulation in HUCMSC-Derived Exosome-Mediated Amelioration of Cardiac Aging.
15-oct-2026
novelty 3
per-area 3
strengthens
Urinary organic acid analysis in preventive health assessment and healthy-aging research: A state-of-the-art review of evidence and methodological limitations.
15-oct-2026
novelty 3
per-area 3
strengthens
Association of Frailty Status with Semi-Targeted Metabolomics and Untargeted Proteomics in Older Adults Referred for Physical Therapy in a Geriatric Clinic.
12-oct-2026
novelty 2
per-area 2
strengthens
Lysine degradation-related metabolic remodeling in sarcopenia: Mendelian randomization prioritization and multi-omics-based characterization.
07-oct-2026
novelty 3
per-area 3
strengthens
Plasma proteomic signatures of biological aging and metabolic dysfunction-associated steatotic liver disease risk: a prospective cohort study.
07-oct-2026
novelty 3
per-area 3
strengthens
Intrinsic capacity modifies the risk of depression and anxiety through metabolomic signature.
06-oct-2026
novelty 3
per-area 3
strengthens
Metabolic and Functional Consequences of Aging in Health and Disease
05-oct-2026
novelty 2
per-area 2
mentions
Multimodal Ageing Biomarkers and Plasma Proteomic Signatures Associated With All‐Cause Mortality
02-oct-2026
novelty 3
per-area 3
strengthens
Proteomic and bioinformatic profiling of the aging mouse heart-diaphragm system.
02-oct-2026
novelty 2
per-area 2
strengthens
Organ-Specific Proteomic Aging Clocks Reveal Complexities Underlying the Healthy Drinking Paradox.
01-oct-2026
novelty 3
per-area 3
strengthens
Multimodal Ageing Biomarkers and Plasma Proteomic Signatures Associated With All-Cause Mortality.
01-oct-2026
novelty 3
per-area 3
strengthens
A Deep-Learning Based Biomarker of Systemic Cellular Senescence Burden to Predict Mortality and Health Outcomes.
01-oct-2026
novelty 4
per-area 4
strengthens
Traditional Chinese Medicine Formulas in Delaying Aging: From Theoretical Foundations to Molecular Mechanisms and Translational Perspectives.
01-oct-2026
novelty 3
per-area 3
strengthens
Westlake Longevity Cohort
29-sep-2026
novelty 3
per-area 3
strengthens
Uncertainty redefines biological age
28-sep-2026
novelty 4
per-area 4
strengthens
Plasma and cerebrospinal fluid proteomics reveal distinct patterns of senescence and neuropathology in aging rhesus macaques.
26-sep-2026
novelty 3
per-area 3
strengthens
Longitudinal proteomic organ-specific aging in heart failure.
25-sep-2026
novelty 4
per-area 4
strengthens
Organ‐Specific Proteomic Aging Clocks Reveal Complexities Underlying the Healthy Drinking Paradox
24-sep-2026
novelty 3
per-area 3
strengthens
CSenescence-associated-secretory phenotype proteins and inflammatory pathways are involved in psychosis: A transdiagnostic study using the Human Connectome Project for early psychosis (HCP-EP) data.
20-sep-2026
novelty 3
per-area 3
strengthens
Sex-specific biological aging clocks across organs and omics.
16-sep-2026
novelty 4
per-area 4
strengthens
Quantitative proteomics reveals coordinated changes in the proteome during replicative senescence.
16-sep-2026
novelty 3
per-area 3
strengthens
Common and distinct plasma proteomic signature of aerobic and motor physical activity interventions and their link to episodic memory.
15-sep-2026
novelty 3
per-area 3
strengthens
Proteomic signatures of systemic inflammation in aging, multimorbidity, and mortality.
12-sep-2026
novelty 3
per-area 3
strengthens
The redox architecture of gestational diabetes mellitus: from cellular stress engine to epigenetic and mitochondrial rewiring.
09-sep-2026
novelty 3
per-area 3
strengthens
Age Acceleration in Various Proteomic Clocks Correlates with Risk of Mortality and Age-Related Disease
08-sep-2026
novelty 2
per-area 2
strengthens
Integration of proteomic aging clocks in a phase 2a clinical trial supports simultaneous geroprotective assessment
07-sep-2026
novelty 3
per-area 3
strengthens
An open benchmark and language models for AI in aging biology.
01-sep-2026
novelty 4
per-area 4
strengthens
Integrative Analysis Uncover the Effects and Multi‐Omics Features of Thigh Muscle Fat Infiltration
01-sep-2026
novelty 2
per-area 2
strengthens
LivAge: An Online Aging Clock for Murine Transcriptomic Age Estimation.
01-sep-2026
novelty 3
per-area 2
strengthens
Genetic and Epigenetic Signatures of Translational Aging Laboratory Testing (GESTALT)
31-aug-2026
novelty 2
per-area 2
mentions
Identifying novel druggable targets and repurposable drugs for premature ovarian insufficiency by integrated multiomics and causal inference analysis.
28-aug-2026
novelty 3
per-area 3
strengthens
Associations Between Accelerometer‐Assessed Sleep Patterns, Proteomic Signatures, and Hallmarks of Aging in Adulthood
27-aug-2026
novelty 3
per-area 3
strengthens
Metabolic Profiling of Epigenetic Aging and Its Associations With Aging‐Related Phenotypes and Modifiable Lifestyle Factors
24-aug-2026
novelty 2
per-area 3
strengthens
Fasting plasma amino acid profiles after resistance exercise with or without nutritional supplementation in older adults: an exploratory analysis of secondary outcomes from a randomized controlled trial.
19-aug-2026
novelty 2
per-area 2
strengthens
Multivariable-adjusted multi-omics signatures reveal gut microbial functional alterations and metabolic dysregulation in intrinsic capacity decline.
18-aug-2026
novelty 3
per-area 3
strengthens
A Novel Approach Utilizing Organ Specific Age Proteomics
18-aug-2026
novelty 3
per-area 3
strengthens
Proteomics of aging: biomarkers for physiological systems and diseases.
14-aug-2026
novelty 2
per-area 3
strengthens
Beyond senescence entry: Individual-cell fates, population outcomes and therapeutic implications in ageing and disease.
11-aug-2026
novelty 3
per-area 2
mentions
Genetic drivers of protein changes over time: Findings, considerations, and approaches in TOPMed cohorts and UK Biobank.
07-aug-2026
novelty 3
per-area 3
strengthens
A machine learning-derived aging-related gene signature for diagnosing HCV cirrhosis: Insights into immune microenvironment and therapeutic targets.
03-aug-2026
novelty 2
per-area 2
mentions
Anti-Obesity Medications in Longevity and Aesthetic Medicine.
03-aug-2026
novelty 3
per-area 2
mentions
Rhythmic Metabolism in Osteosarcopenia: Emerging Evidence, a Chronometabolomic Framework for the Bone-Muscle Unit, and Research Priorities.
02-aug-2026
novelty 3
per-area 3
strengthens
Epigenetic aging in Alzheimer's disease: Relation to proteome.
01-aug-2026
novelty 3
per-area 3
strengthens